These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10492213)

  • 1. Re: Comparison of screening methods in the detection of bladder cancer.
    Johnston B; Morales A
    J Urol; 1999 Oct; 162(4):1388-9. PubMed ID: 10492213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Which role and which tools in the screening of bladder cancer today?].
    Pfister C
    Prog Urol; 2003 Nov; 13(5 Suppl 2):1225-6. PubMed ID: 15816388
    [No Abstract]   [Full Text] [Related]  

  • 3. Urothelial bladder cancer: biomarkers for detection and screening.
    Konety B; Lotan Y
    BJU Int; 2008 Nov; 102(9 Pt B):1234-41. PubMed ID: 19035887
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term outcome of hematuria home screening for bladder cancer in men.
    Cai T; Bartoletti R
    Cancer; 2007 May; 109(9):1923-4; author reply 1924. PubMed ID: 17357998
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Early results of bladder-cancer screening in a high-risk population of heavy smokers.
    Byrne D
    BJU Int; 2009 Jan; 103(1):116. PubMed ID: 19076973
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.
    Kakizoe T; Mucci LA; Albertsen PC; Droller MJ
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):191-212. PubMed ID: 18815934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mass screening of cancer of the urinary tract].
    Nakamura S
    Gan No Rinsho; 1970; 16(3):202-4. PubMed ID: 5463013
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Comparison of screening methods in the detection of bladder cancer.
    Anderson J
    J Urol; 1999 Oct; 162(4):1388; author reply 1389. PubMed ID: 10492212
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening and monitoring for bladder cancer: refining the use of NMP22.
    Ponsky LE; Sharma S; Pandrangi L; Kedia S; Nelson D; Agarwal A; Zippe CD
    J Urol; 2001 Jul; 166(1):75-8. PubMed ID: 11435827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state of screening for bladder cancer.
    Madeb R; Golijanin D; Knopf J; Messing EM
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):981-7. PubMed ID: 17627458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for bladder cancer in the rubber industry.
    Parkes HG
    Proc R Soc Med; 1973 Mar; 66(3):289. PubMed ID: 4698002
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary bladder tumor markers.
    Lokeshwar VB; Selzer MG
    Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening.
    Marsh GM; Cassidy LD
    Am J Ind Med; 2003 Feb; 43(2):142-8. PubMed ID: 12541268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical efficacy of Bladder Chek NMP22 in urothelial cancer].
    Yokoyama T; Sekigawa R; Hayashi T; Horita S; Kanamuro T; Nonami Y; Sawada T; Nishikawa T; Kobayashi M; Yamaguchi Y; Ishida H; Goya N; Nakazawa H; Toma H
    Rinsho Byori; 2004 Mar; 52(3):199-203. PubMed ID: 15137316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer screening study initiated by Fox Chase.
    Oncology (Williston Park); 1990 Jan; 4(1):16. PubMed ID: 2144178
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.
    Hedelin H; Jonsson K; Salomonsson K; Boman H
    Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply from authors re: Brant A. Inman, Michael R. Abern. Interpreting a study on bladder cancer screening. Eur Urol 2013;64:48-50: the goal of cancer screening: early evaluation of screening for bladder cancer.
    Roobol MJ; Bangma CH; Steyerberg EW
    Eur Urol; 2013 Jul; 64(1):50-1. PubMed ID: 23623479
    [No Abstract]   [Full Text] [Related]  

  • 18. Bladder cancer biomarkers and their role in surveillance and screening.
    Van Tilborg AA; Bangma CH; Zwarthoff EC
    Int J Urol; 2009 Jan; 16(1):23-30. PubMed ID: 19120523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of hematuria home screening for bladder cancer in men.
    Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C
    Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations].
    Fukui Y; Samma S; Fujimoto K; Akiyama T; Yamaguchi A; Hirayama A
    Hinyokika Kiyo; 2001 May; 47(5):311-4. PubMed ID: 11433750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.